A Cancer Stem Cell Vaccine Engineered to Express Interleukin-15 and its Receptor Induces T Cell Proliferation

被引：0
|
作者：
Toukam, Donatien K. [1 ]
Steel, Jason C. [2 ]
Carwell, Christian [1 ]
Eldessouki, Ihab [1 ]
Morris, John C. [1 ]
机构：
[1] Univ Cincinnati, Div Hematol Oncol, Cincinnati, OH USA
[2] Univ Queensland, Gallipoli Med Res Inst, Brisbane, Qld, Australia
来源：
MOLECULAR THERAPY | 2017年 / 25卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
339
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [1] Adult T-cell leukemia cells express interleukin-15 receptor and proliferate in response to interleukin-15
    Yamada, Y
    Sugawara, K
    Tsuruta, K
    Maeda, T
    Tomonaga, M
    Kamihira, S
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 811 - 811
  • [2] Interleukin-15 induces T cell activation in inflammatory bowel disease
    Liu, ZJ
    Colpaert, S
    Ade, M
    D'Haens, G
    Geboes, K
    Ceuppens, J
    Rutgeerts, P
    GASTROENTEROLOGY, 1999, 116 (04) : A764 - A765
  • [3] Effects of interleukin-15 on in vitro human T cell proliferation and activation
    Hasan, MS
    Kallas, EG
    Thomas, EK
    Looney, J
    Campbell, M
    Evans, TG
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2000, 20 (02): : 119 - 123
  • [4] Interleukin-15 induces adhesion receptor redistribution in T lymphocytes
    Nieto, M
    delPozo, MA
    SanchezMadrid, F
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) : 1302 - 1307
  • [5] Interleukin-15 and Its Receptor Enhance Antitumor Activity Following a Genetically Modified Dendritic Cell Vaccine
    Steel, Jason C.
    Ramlogan, Charmaine A.
    Yu, Ping
    Waldmann, Thomas A.
    Morris, John C.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 949 - 949
  • [6] Vaccine cells derived from cancer stem cells expressing interleukin-15 and its receptor inhibit tumor growth
    Toukam, Donatien Kamdem
    Steel, Jason C.
    Carwell, Christian
    Eldessouki, Ihab
    Morris, John C.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [7] Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency
    Zhang, Yi
    Tian, Shenghe
    Liu, Zuqiang
    Zhang, Jiying
    Zhang, Meili
    Bosenberg, Marcus W.
    Kedl, Ross M.
    Waldmann, Thomas A.
    Storkus, Walter J.
    Falo, Louis D., Jr.
    You, Zhaoyang
    ONCOIMMUNOLOGY, 2014, 3 (10) : e959321 - 1
  • [8] Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor α Chain, Epithelial-to-Mesenchymal Transition
    Khawam, Krystel
    Giron-Michel, Julien
    Gu, Yanhong
    Perier, Aurelie
    Giuliani, Massimo
    Caignard, Anne
    Devocelle, Aurore
    Ferrini, Silvano
    Fabbi, Marina
    Charpentier, Bernard
    Ludwig, Andreas
    Chouaib, Salem
    Azzarone, Bruno
    Eid, Pierre
    CANCER RESEARCH, 2009, 69 (04) : 1561 - 1569
  • [9] Ultralong CDR3 engineered interleukin-15 antibody fusion for T and NK cell expansion
    Huang, Ruiqi
    McGregor, Duncan
    Smider, Vaughn
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Interleukin-15 expression in cutaneous T-cell lymphoma
    Leroy, S
    Dubois, S
    Tenaud, I
    Chebassier, N
    Godard, A
    Jacques, Y
    Dreno, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 487 - 487
12345